Amélie Petitprez

415 citations
6 papers · 334 indexed · h-index 6
Topics
Cancer therapeutics and mechanisms (4 papers)Colorectal Cancer Treatments and Studies (4 papers)HER2/EGFR in Cancer Research (2 papers)
Partner nations
France

In The Last Decade

Amélie Petitprez

6 papers receiving 329 citations

Peers

Amélie Petitprez
Comparison fields: 5 of 54
  • Molecular Biology 178
  • Oncology 159
  • Pulmonary and Respiratory Medicine 122
  • Cancer Research 75
  • Radiology, Nuclear Medicine and Imaging 28
Replace Jinwei Hao with:
Jinwei Hao Australia
David Surguladze United States
Özge Gümüşay Türkiye
Loreley Calvet France
Sonia Garofalo Italy
Napa Parinyanitikul Thailand
Jugang Wu China
Bastianina Canu Italy
Eri Taguchi Japan
K. Papadopoulos United States
Amélie Petitprez relative to Jinwei Hao Australia Jinwei Hao's profile →
Citations per field
00.5×1.5×
Jinwei Hao · 1×
Citations per year

Countries citing papers authored by Amélie Petitprez

Since Specialization
Citations

This map shows the geographic impact of Amélie Petitprez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amélie Petitprez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amélie Petitprez more than expected).

Fields of papers citing papers by Amélie Petitprez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amélie Petitprez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amélie Petitprez. The network helps show where Amélie Petitprez may publish in the future.

Co-authorship network of co-authors of Amélie Petitprez

This figure shows the co-authorship network connecting the top 25 collaborators of Amélie Petitprez. A scholar is included among the top collaborators of Amélie Petitprez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amélie Petitprez. Amélie Petitprez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 29
2 5
3 20
4 32
5 205
6 43

About Amélie Petitprez

Amélie Petitprez is a scholar working on Oncology, Hepatology and Molecular Biology, having authored 6 papers that have together received 334 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (159 citations), Cancer Research (75 citations) and Pulmonary and Respiratory Medicine (122 citations). Amélie Petitprez has collaborated with scholars based in France. Frequent co-authors include Annette K. Larsen, Djamila Ouaret, Alexandre E. Escargueil, Virginie Poindessous, Éric Guérin, Marie Regairaz, Gérard Bastian, Aimery de Gramont, Benoist Chibaudel and Sylvie Dumont. Their work appears in journals such as Clinical Cancer Research, Pharmacology & Therapeutics and Current Pharmaceutical Design.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026